TG
UTHR icon

TCW Group’s United Therapeutics UTHR Stock Holding History

TCW Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$345K Sell
637
-19
-3% -$10.7K ﹤0.01% 565
2026
Q1 		$389K Buy
656
+32
+5% +$15.9K ﹤0.01% 520
2025
Q4 		$304K Buy
+624
New +$291K ﹤0.01% 573

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

TCW Group's UTHR Position: Q2 2026 in Review

TCW Group reduced its United Therapeutics (UTHR) stake by 2.9% in Q2 2026, selling an estimated $10.7K and leaving 637 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #565.

TCW Group first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. The position peaked at $389K in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • TCW Group held 637 shares of United Therapeutics worth $345K as of Q2 2026.
  • TCW Group sold 19 United Therapeutics shares in Q2 2026, an estimated $10.7K.
  • United Therapeutics made up ﹤0.01% of TCW Group's portfolio in Q2 2026, its #565 holding.
  • TCW Group first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • TCW Group's United Therapeutics position peaked at $389K in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on TCW Group's 13F filing for Q2 2026, filed 3 Aug 2026.